Comparison of gallbladder function obtained with regular CCK-8 and pharmacy-compounded CCK-8

Journal of Nuclear Medicine

Volumn 44, Issue 4, 2003, Pages 499-504

  Krishnamurthy, Shakuntala ^a   Cerulli Switzer, Jeri ^a   Chapman, Nicholas ^a   Krishnamurthy, Gerbail T ^a  

^a Tuality Community Hospital   (United States)

Author keywords

Chronic cholecystitis; Gallbladder ejection fraction; Pharmacy compounded octapeptide of cholecystokinin; Sincalide

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; DIAGNOSTIC AGENT; DISOFENIN TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INFUSION; FEMALE; FUNCTIONAL ASSESSMENT; GALLBLADDER DISEASE; GALLBLADDER FUNCTION; GALLBLADDER SCINTISCANNING; HUMAN; LATENT PERIOD; MALE; MEASUREMENT; PATIENT; PHARMACY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TIME; CLASSIFICATION; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFECT; DRUG FORMULATION; GALLBLADDER; GALLBLADDER EMPTYING; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; DRUG APPROVAL; DRUG COMPOUNDING; FEMALE; GALLBLADDER; GALLBLADDER DISEASES; GALLBLADDER EMPTYING; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SINCALIDE; TECHNETIUM TC 99M DISOFENIN;

EID: 0038315450     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Krishnamurthy S, Krishnamurthy GT. Biliary dyskinesia role of the sphincter of Oddi, gallbladder, and cholecystokinin. J Nucl Med. 1997;38:1824-1830.
2. Krishnamurthy GT, Bobba VR, McConnell D, et al. Quantitative biliary dynamics: introduction of a new non-invasive scintigraphic technique. J Nucl Med 1983;24:217-223.
3. Bobba VR, Krishnamurthy GT, Kingston E, et al. Gallbladder dynamics induced by a fatty meal in normal subjects and patients with gallstones. J Nucl Med. 1984;25:21-24.
4. Krishnamurthy GT, Brown PH Comparison of fatty meal and intravenous cholecystokinin infusion for gallbladder ejection fraction. J Nucl Med. 2002;43: 1603-1610.
5. Alternatives to Kinevac: shortages lead to inventive measures. J Nucl Med. 2002;43(3):20N-28N
6. Krishnamurthy GT, Krishnamurthy S. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases New York. NY Springer; 2000
7. Sturdevant RA, Stern DH, Resin H, et al Effect of graded doses of octapeptide of cholecystokinin on gallbladder size in man Gastroenterology. 1973;64:452-456.
8. Kinevac [package insert] Princeton, NJ. Bracco Diagnostic, Inc.; May 2002.
9. Krishnamurthy GT, Bobba VR, Kingston E. Optimization of octapeptide of cholecystokinin (OP-CCK) dose for gallbladder emptying. In: Raynaud C. ed. Proceedings of the Third World Congress of Nuclear Medicine and Biology Paris, France: Pergamon Press; 1982:2244-2247
10. Ziessman HA, Fahey FH, Hixson DJ. Calculation of a gallbladder ejection fraction advantage of continuous sincalide infusion over the three-minute method. J Nucl Med 1992;33:537-541.
11. Ziessman HA, Muenz LR, Agarwal AK, Zaza AAM. Normal values for sincalide cholescintigraphy: comparison of two methods. Radiology. 2001;221:404-410.
12. Krishnamurthy GT, Bobba VR, Kingston E, Turner FE. Measurement of gallbladder emptying sequentially using a single dose of Tc-99m labeled hepatobiliary agent. Gastroenterology. 1982;83:773-776.
13. Sostre S, Canto MI, Kalloo AN. Gallbladder response to a second dose of cholecystokinin during the same imaging study. Eur J Nucl Med. 1992;19:964-965.
14. Fink-Bennett D, DeRidder R, Kolozsi WZ, et al. Cholecystokinin cholescintigraphy: detection of abnormal gallbladder motor function in patients with chrome acalculous cholecystitis J Nucl Med. 1991;32:1695-1699.
15. Misra DC, Blossom GB, Fink-Bennett D, Glover JL. Results of surgical therapy for biliary dyskinesia. Arch Surg. 1991;126:957-960.
16. Zeck ER, Simmons LB, Kendrick RR, et al. Cholecystokinin enhanced hepatobiliary scanning with ejection fraction calculation as an indicator of disease of the gallbladder. Surg Gynecol Obstet. 1991;172:21-24.